At the news
? NEUTRALIMPACT 4/10 EFFECT filed Mar 11, 2026 at 00:15 ET
Rocket Pharmaceuticals, Inc. has an effective shelf registration (Form S-3) as of March 10, 2026, allowing the company to issue unspecified securities from time to time. This creates a potential for future dilution, though no specific offering size or terms were disclosed.
- Form S-3 shelf registration became effective on March 10, 2026.
- The filing is a general offering statement, permitting the company to sell securities in one or more offerings without filing a new registration.
- No specific offering size, pricing, or use of proceeds was disclosed in this filing.
- The company may issue common stock, preferred stock, debt, or warrants under this shelf.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access